Inspire Medical Systems, Inc.: current assets
Current assets for Inspire Medical Systems, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All Inspire Medical Systems, Inc. financial histories
What this measure means
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
Exact concept: us-gaap:AssetsCurrent. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2017-12-31 to 2025-12-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 583,652,000 | USD | 2026-02-13 | 10-K · 0001609550-26-000016 |
| At date | 2024-12-31 | 630,806,000 | USD | 2026-02-13 | 10-K · 0001609550-26-000016 |
| At date | 2023-12-31 | 593,739,000 | USD | 2025-02-10 | 10-K · 0001609550-25-000011 |
| At date | 2022-12-31 | 530,032,000 | USD | 2024-02-09 | 10-K · 0001609550-24-000016 |
| At date | 2021-12-31 | 268,537,000 | USD | 2023-02-10 | 10-K · 0001609550-23-000024 |
| At date | 2020-12-31 | 269,869,000 | USD | 2022-02-15 | 10-K · 0001609550-22-000014 |
| At date | 2019-12-31 | 170,636,000 | USD | 2021-02-24 | 10-K · 0001609550-21-000010 |
| At date | 2019-01-01 | 199,270,000 | USD | 2020-02-25 | 10-K · 0001609550-20-000011 |
| At date | 2018-12-31 | 199,278,000 | USD | 2020-02-25 | 10-K · 0001609550-20-000011 |
| At date | 2017-12-31 | 24,097,000 | USD | 2019-02-26 | 10-K · 0001609550-19-000013 |
Related financial histories
- Inspire Medical Systems, Inc.: total assets
- Inspire Medical Systems, Inc.: total liabilities
- Inspire Medical Systems, Inc.: stockholders equity
- Inspire Medical Systems, Inc.: cash and cash equivalents
- Inspire Medical Systems, Inc.: net income or loss
- Inspire Medical Systems, Inc.: operating cash flow
- Inspire Medical Systems, Inc.: capital expenditure payments
- Inspire Medical Systems, Inc.: revenue
- Inspire Medical Systems, Inc.: contract revenue excluding tax
- Inspire Medical Systems, Inc.: financing cash flow
- Inspire Medical Systems, Inc.: investing cash flow
- Inspire Medical Systems, Inc.: retained earnings or deficit
- Inspire Medical Systems, Inc.: basic weighted-average shares
- Inspire Medical Systems, Inc.: diluted weighted-average shares
- Inspire Medical Systems, Inc.: basic earnings per share
- Inspire Medical Systems, Inc.: diluted earnings per share
- Inspire Medical Systems, Inc.: income tax expense or benefit
- Inspire Medical Systems, Inc.: net property, plant and equipment
- Inspire Medical Systems, Inc.: share-based compensation expense
- Inspire Medical Systems, Inc.: operating income or loss
- Inspire Medical Systems, Inc.: interest expense
- Inspire Medical Systems, Inc.: current liabilities
- Inspire Medical Systems, Inc.: net current accounts receivable
- Inspire Medical Systems, Inc.: common-stock repurchase payments
- Inspire Medical Systems, Inc.: operating expenses
- Inspire Medical Systems, Inc.: net inventory
- Inspire Medical Systems, Inc.: gross profit
- Inspire Medical Systems, Inc.: cost of revenue
- Inspire Medical Systems, Inc.: selling, general and administrative expense
- Inspire Medical Systems, Inc.: research and development expense
Inspect the source
- Entity
- Inspire Medical Systems, Inc. / CIK 0001609550
- Captured
- 2026-09-20T09:26:33.934Z
- SEC response SHA-256
34ab26804128582b0f27b7da555ba7c84fcbc74f86ce7bd77e4beecd5f5a0297
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001609550.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))